no code implementations • 10 Apr 2024 • Chloe Herman, Bridget M. Barker, Thais F. Bartelli, Vidhi Chandra, Rosa Krajmalnik-Brown, Mary Jewell, Le Li, Chen Liao, Florencia McAllister, Khemlal Nirmalkar, Joao B. Xavier, J. Gregory Caporaso
Quantifying the extent of engraftment following an FMT is important in determining if a recipient didn't respond because the engrafted microbiome didn't produce the desired outcomes (a successful FMT, but negative treatment outcome), or the microbiome didn't engraft (an unsuccessful FMT and negative treatment outcome).